M-CPP and Fenfluramine in Cocaine Addicts - 3

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: M-CPP

Study type

Interventional

Funder types

Other U.S. Federal agency
NIH

Identifiers

NCT00000314
NIDA-09468-3
R01-09468-3

Details and patient eligibility

About

The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.

Sex

Male

Ages

25 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems